Home

Martha Enger Lab

Main content

Professor Martha Chekenya Enger

Welcome to the Brain Tumor Immunology & Therapy lab

The group is led by Dr Martha Chekenya Enger and is one of five labs that form the larger Translational Cancer Research Group

Publications (PubMed)

BTi - Moving Basic Research Closer To the Clinic

hampered progress of clinical trials in oncology
covid-19_effect_on_the_clinical_trial_bortem-17

The effect of the COVID-19 pandemic on clinical brain cancer trials

2020 evolved into an annus horribilis for everyone, manifested by physical distancing and social isolation, disrupted work routines and for many, tragic loss of livelihood and loved ones.

User involvement
Hjernesvulstforeningen besøker Brain tumor Immunology and Therapy Group hos Instituttet for biomedisin

Patient organization collaborates with researchers to improve brain cancer therapy

The research laboratory for brain cancer immunology and therapy at the Department of Biomedicine has received the secretary general of the Brain-Tumour Society Rolf Ledal to discuss current and future research projects.

Research project
Logo Hjernesvulstforeningen

Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter

This phase IB/II trial is designed to investigate the safety and survival benefits for patients with recurrent glioblastoma with unmethylated MGMT promoter treated with Bortezomib and Temozolomide in a specific schedule.

master's thesis
Picture of Maria Tennefoss Sørbø

Master's thesis in medical school: Maria Tennefoss Sørbø

We congratulate Maria Tennefos Sørbø who has completed and passed her master's thesis in medical school. The study was conducted in the period 2019-2021.